HLS Therapeutics Inc. (OTCMKTS:HLTRF) Short Interest Update

HLS Therapeutics Inc. (OTCMKTS:HLTRF) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 3,200 shares, a growth of 3,100.0% from the February 28th total of 100 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 32.0 days.

HLS Therapeutics Price Performance

Shares of OTCMKTS HLTRF opened at $3.22 on Friday. HLS Therapeutics has a 1 year low of $2.22 and a 1 year high of $4.00. The firm has a 50-day simple moving average of $2.86 and a two-hundred day simple moving average of $2.67.

About HLS Therapeutics

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.